These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17446293)

  • 1. Enhancement of salivary IgA response to a DNA vaccine against Streptococcus mutans wall-associated protein A in mice by plasmid-based adjuvants.
    Han TK; Dao ML
    J Med Microbiol; 2007 May; 56(Pt 5):675-680. PubMed ID: 17446293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential immunogenicity of a DNA vaccine containing the Streptococcus mutans wall-associated protein A gene versus that containing a truncated derivative antigen A lacking in the hydrophobic carboxyterminal region.
    Han TK; Dao ML
    DNA Cell Biol; 2005 Sep; 24(9):574-81. PubMed ID: 16153158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine.
    Su LK; Yu F; Li ZF; Zeng C; Xu QA; Fan MW
    Acta Pharmacol Sin; 2014 May; 35(5):592-8. PubMed ID: 24705100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.
    Katz J; Harmon CC; Buckner GP; Richardson GJ; Russell MW; Michalek SM
    Infect Immun; 1993 May; 61(5):1964-71. PubMed ID: 8478086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats.
    Liu GX; Xu QA; Jin J; Li YH; Jia R; Guo JH; Fan MW
    Vaccine; 2009 May; 27(22):2940-7. PubMed ID: 19428904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.
    Zhang P; Jespersgaard C; Lamberty-Mallory L; Katz J; Huang Y; Hajishengallis G; Michalek SM
    Infect Immun; 2002 Dec; 70(12):6779-87. PubMed ID: 12438353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunogenicity of an anti-caries vaccine encoding a cell-surface protein antigen of Streptococcus mutans by intranasal DNA prime-protein boost immunization.
    Li Y; Jin J; Yang Y; Bian Z; Chen Z; Fan M
    J Gene Med; 2009 Nov; 11(11):1039-47. PubMed ID: 19718694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.
    Russell MW; Wu HY
    Infect Immun; 1991 Nov; 59(11):4061-70. PubMed ID: 1937766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
    Wu HY; Russell MW
    Infect Immun; 1993 Jan; 61(1):314-22. PubMed ID: 8418053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
    Wu HY; Russell MW
    Vaccine; 1998; 16(2-3):286-92. PubMed ID: 9607044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Streptococcus mutans wall-associated protein A gene in Chinese hamster ovary cells: prospect for a dental caries DNA vaccine.
    Han TK; Yoder S; Cao C; Ugen KE; Dao ML
    DNA Cell Biol; 2001 Sep; 20(9):595-601. PubMed ID: 11747611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intranasal immunization against dental caries with plasmid DNA encoding pac gene of Streptococcus mutans in gnotobiotic rats].
    Guo J; Fan M; Bian Z; Jia R; Peng B
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):452-5. PubMed ID: 12641962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1.
    Batista MT; Ferreira EL; Pereira GS; Stafford P; Maeda DLNF; Rodrigues JF; Brady LJ; Johnston SA; Ferreira LCS; Ferreira RCC
    Vaccine; 2017 Dec; 35(52):7273-7282. PubMed ID: 29146379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
    Saito M; Otake S; Ohmura M; Hirasawa M; Takada K; Mega J; Takahashi I; Kiyono H; McGhee JR; Takeda Y; Yamamoto M
    J Infect Dis; 2001 Mar; 183(5):823-6. PubMed ID: 11181162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.
    Childers NK; Miller KL; Tong G; Llarena JC; Greenway T; Ulrich JT; Michalek SM
    Infect Immun; 2000 Oct; 68(10):5509-16. PubMed ID: 10992447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective efficacy of a new fusion anti-caries DNA vaccine encoding antigens of both Streptococcus mutans and Streptococcus sobrinus].
    Sun JH; Niu YM; Fan MW; Xu QA; Yang XC
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2286-91. PubMed ID: 20095345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine.
    Yan H
    Sci China Life Sci; 2013 May; 56(5):406-13. PubMed ID: 23633072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An experimental study on PAc and GTF gene vaccines of Streptococcus mutans against rats caries: antibody levels in saliva and serum].
    Yang D; Liu T; Cao F
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Oct; 21(5):396-9. PubMed ID: 14651001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term persistence and recall of immune responses in aged mice after mucosal immunization.
    Harrod T; Martin M; Russell MW
    Oral Microbiol Immunol; 2001 Jun; 16(3):170-7. PubMed ID: 11358539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine.
    Sun Y; Shi W; Yang JY; Zhou DH; Chen YQ; Zhang Y; Yang Y; He BX; Zhong MH; Li YM; Cao Y; Xiao Y; Li W; Yu J; Li YH; Fan MW; Yan HM
    J Dent Res; 2012 Oct; 91(10):941-7. PubMed ID: 22895510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.